Skip to content
Navinci
  • Science
  • Solutions
  • About
LET’S CONNECT

News

November 6, 2024

New kits for Leica BOND RX/RXm with fluorescent readout

Read more about New kits for Leica BOND RX/RXm with fluorescent readout →
October 23, 2024

Jenny Sundqvist appointed CEO of Navinci

Read more about Jenny Sundqvist appointed CEO of Navinci →
September 27, 2024

Precision for Medicine and Navinci Announce Strategic Partnership

Read more about Precision for Medicine and Navinci Announce Strategic Partnership →
September 19, 2024

Navinci announces stepping down of CEO, Robert Gunnarsson

Read more about Navinci announces stepping down of CEO, Robert Gunnarsson →
September 6, 2024

Partnership announced between Canopy Biosciences and Navinci

Read more about Partnership announced between Canopy Biosciences and Navinci →
September 4, 2024

Navinci strengthens leadership with new Director of Operations

Read more about Navinci strengthens leadership with new Director of Operations →
June 28, 2024

Andrea Ballagi joins Navinci Board of Directors

Read more about Andrea Ballagi joins Navinci Board of Directors →
June 13, 2024

Leica Biosystems and Navinci Partner to Accelerate Cancer Research

Read more about Leica Biosystems and Navinci Partner to Accelerate Cancer Research →
May 8, 2024

Navinci Housewarming Party

Read more about Navinci Housewarming Party →
April 8, 2024

Navinci Presents Cutting-Edge Cancer Research at AACR24

Read more about Navinci Presents Cutting-Edge Cancer Research at AACR24 →
March 21, 2024

Navinci expands into new facilities

Read more about Navinci expands into new facilities →
February 28, 2024

Product launch: Naveni® CD8/MHC-I  kit

Read more about Product launch: Naveni® CD8/MHC-I  kit →
← Newer 1 2 3 4 … 7 Older →
Navinci
  • Science
  • Solutions
  • About
NEWS
SIGN UP FOR PRESS RELEASES
Navinci on LinkedIn

Terms of Use

© Navinci Diagnostics AB. All rights reserved.

All Navinci products and services may only be used in accordance with their intended purpose. Any resale, redistribution, or other commercial use (including as part of service offerings) of Navinci Diagnostics’ products or services, or any of their components, requires prior written permission from the company. Unauthorized commercialization is strictly prohibited and may result in legal action.